Elutia (ELUT) EBT Margin Growth (1y) (2020 - 2026)
Elutia (ELUT) EBT Margin Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.43 Bn | 193.83 Bn | 7.27 Bn | -719.00 |
| 2 | Stryker | 126.52 Bn | 123.04 Bn | 4.50 Bn | 687.00 |
| 3 | Medtronic | 118.76 Bn | 109.54 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 88.00 |
| 5 | Edwards Lifesciences | 52.20 Bn | 47.95 Bn | 1.35 Bn | 374.00 |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 343.00 |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.65 Bn | 2.18 Bn | 84.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -126.00 |
| 9 | Steris | 23.09 Bn | 22.61 Bn | 684.20 Mn | 165.00 |
| 10 | Elutia | 40.24 Mn | 20.35 Mn | 1.45 Mn | -5,686.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18,758.00 |
| Dec 31, 2025 | 5,465.00 |
| Sep 30, 2025 | -10,268.00 |
| Jun 30, 2025 | 29,766.00 |
| Mar 31, 2025 | 20,502.00 |
| Dec 31, 2024 | 522.00 |
| Sep 30, 2024 | 23,024.00 |
| Jun 30, 2024 | -32,945.00 |
| Mar 31, 2024 | -11,586.00 |
| Dec 31, 2023 | -16,789.00 |
| Sep 30, 2023 | 4,951.00 |
| Jun 30, 2023 | -4,726.00 |
| Mar 31, 2023 | -8,204.00 |
| Dec 31, 2022 | -800.00 |
| Sep 30, 2022 | -11,605.00 |
| Jun 30, 2022 | -5,480.00 |
| Mar 31, 2022 | -3,156.00 |
| Dec 31, 2021 | -4,044.00 |
| Sep 30, 2021 | -1,520.00 |
| Jun 30, 2021 | 4,083.00 |